53 results
424B5
SLNO
Soleno Therapeutics Inc
2 May 24
Prospectus supplement for primary offering
4:04pm
on sameness, and their association with maladaptive conduct problems. Cognitively, most individuals with PWS function in the mild intellectual disability
8-K
EX-10.1
SLNO
Soleno Therapeutics Inc
30 Jan 24
Departure of Directors or Certain Officers
4:57pm
under Form S-8 promulgated under the Securities Act.
(l) “Director” means a member of the Board.
(m) “Disability” means total and permanent … disability, as determined by the Administrator in its discretion in accordance with uniform and non-discriminatory standards adopted by the Administrator from
424B5
xd0pdmxl2ibpzo
29 Sep 23
Prospectus supplement for primary offering
4:51pm
424B5
jj06njcclr
27 Sep 23
Prospectus supplement for primary offering
5:26pm
424B5
g7mpw
30 Mar 22
Prospectus supplement for primary offering
5:21pm
424B5
l2hk2m8 5j6r
28 Mar 22
Prospectus supplement for primary offering
4:53pm
424B5
n753gky2b
16 Jul 21
Prospectus supplement for primary offering
4:07pm
8-K
EX-10.3
fuultp60s90uxxga
13 Jan 21
Departure of Directors or Certain Officers
4:05pm
8-K
EX-10.1
2r1j 27x7
13 Nov 20
Termination of a Material Definitive Agreement
4:02pm
8-K
EX-10.1
od5 y6auv7v
2 Oct 20
Departure of Directors or Certain Officers
4:49pm
S-8
EX-4.2
1z6xsujux
26 Jun 20
Registration of securities for employees
5:01pm